home / stock / livn / livn news


LIVN News and Press, LivaNova PLC From 04/14/23

Stock Information

Company Name: LivaNova PLC
Stock Symbol: LIVN
Market: NASDAQ
Website: livanova.com

Menu

LIVN LIVN Quote LIVN Short LIVN News LIVN Articles LIVN Message Board
Get LIVN Alerts

News, Short Squeeze, Breakout and More Instantly...

LIVN - LivaNova CEO to step down, co sees preliminary Q1 revenue above consensus

2023-04-14 17:01:46 ET LivaNova ( NASDAQ: LIVN ) on Friday announced the resignation of its CEO and preliminary Q1 revenue that was above consensus estimates. Damien McDonald resigned as LIVN's CEO, the company said in a statement , with chair of the board William Kozy app...

LIVN - LivaNova Board of Directors Announce Leadership Changes

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald has resigned as Chief Executive Officer. Effective immediately, Chair of the Board William A. Kozy is appointed interim CEO to help the executive leadership team maintain ...

LIVN - Oakmark Equity And Income Fund:  Q1 2023 Commentary

2023-04-13 03:45:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

LIVN - LivaNova to Announce First-Quarter 2023 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2023 results prior to th...

LIVN - LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM). With FDA clearance, LivaNova initiates the commercial launch of Essenz in ...

LIVN - LivaNova to Present at the Barclays Global Healthcare Conference

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will take place at 9 a.m. Eastern Tim...

LIVN - Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2022 Update

2023-03-05 22:12:31 ET Summary David Einhorn's 13F stock portfolio value increased from $1.41B to $1.44B this quarter. Greenlight added Tenet Healthcare and increased Kyndryl Holdings, Southwestern Energy, and Global Payments during the quarter. The largest three positions are...

LIVN - LivaNova ticks higher amid vague takeover speculation

LivaNova (LIVN ) rose 2.2% amid some vague takeover speculation following the company's Q4 results and some amendments for executive compensation in a potential acquisition. LivaNova ( NASDAQ: LIVN ) disclosed on Wednesday in a filing that it's compensation committee amended s...

LIVN - LivaNova PLC (LIVN) Q4 2022 Results - Earnings Call Transcript

LivaNova PLC (LIVN) Q4 2022 Results Earnings Conference Call February 22, 2023, 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conf...

LIVN - LivaNova PLC 2022 Q4 - Results - Earnings Call Presentation

The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q4 earnings call. For further details see: LivaNova PLC 2022 Q4 - Results - Earnings Call Presentation

Previous 10 Next 10